Literature DB >> 2754543

Metallothionein and copper in liver disease with copper retention--a histopathological study.

M E Elmes1, J P Clarkson, N J Mahy, B Jasani.   

Abstract

We have examined the relationship between (a) histochemically demonstrable copper using rubeanic acid, (b) copper-associated protein (CAP) using orcein, and (c) immunoreactive metallothionein (MT) using DNP hapten sandwich staining and have correlated these with histological lesions in 95 liver biopsies from patients with conditions associated with hepatic copper retention, 4 fetal livers, and 25 histologically normal adult controls. No copper or CAP was present in normal adult liver but periportal CAP was present in fetal liver. MT was present in hepatocytes of normal livers with a predominantly perivenular (centrilobular) cytoplasmic distribution varying in staining intensity; all fetal hepatocytes stained strongly for MT. Fifty-two of 95 (55 per cent) abnormal livers contained CAP and 42 (44 per cent) contained both CAP and copper. In CAP-positive livers, the commonest histological lesions were piecemeal necrosis and cholestasis. CAP was present in (a) 15/15 cases of primary biliary cirrhosis including early cases with minimal pathology; and (b) 5/5 cases of Wilson's disease, 6/6 cases of biliary atresia, and 3/9 cases of sclerosing cholangitis. In other conditions, it was present in 25-50 per cent of cases. MT distribution was abnormal in most CAP-positive livers. Necrotic hepatocytes were intensely MT-positive and in Wilson's disease had a characteristic appearance.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2754543     DOI: 10.1002/path.1711580208

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  6 in total

1.  Hepatic Copper Accumulation: A Novel Feature in Transient Infantile Liver Failure Due to TRMU Mutations?

Authors:  Z Grover; P Lewindon; A Clousten; A Shaag; O Elpeleg; D Coman
Journal:  JIMD Rep       Date:  2015-02-10

2.  Immunohistochemical metallothionein expression in colorectal adenocarcinoma: correlation with tumour stage and patient survival.

Authors:  D Ofner; H Maier; B Riedmann; T Bammer; A Rumer; G Winde; W Böcker; B Jasani; K W Schmid
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

3.  Presence and possible significance of immunocytochemically demonstrable metallothionein over-expression in primary invasive ductal carcinoma of the breast.

Authors:  K W Schmid; I O Ellis; J M Gee; B M Darke; W E Lees; J Kay; A Cryer; J M Stark; A Hittmair; D Ofner
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

4.  Immunohistochemical demonstration of metallothionein in normal human breast tissue and benign and malignant breast lesions.

Authors:  B Bier; A Douglas-Jones; M Tötsch; B Dockhorn-Dworniczak; W Böcker; B Jasani; K W Schmid
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

5.  Urinary copper elevation in a mouse model of Wilson's disease is a regulated process to specifically decrease the hepatic copper load.

Authors:  Lawrence W Gray; Fangyu Peng; Shannon A Molloy; Venkata S Pendyala; Abigael Muchenditsi; Otto Muzik; Jaekwon Lee; Jack H Kaplan; Svetlana Lutsenko
Journal:  PLoS One       Date:  2012-06-22       Impact factor: 3.240

6.  Animal models of copper-associated liver disease.

Authors:  I Carmen Fuentealba; Enrique M Aburto
Journal:  Comp Hepatol       Date:  2003-04-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.